| Financial Year |
March 31 2023 |
| Monetary Funds |
170,350,513.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
22,585,085.24 |
| Advances to Suppliers |
55,570,845.27 |
| Other Receivables |
4,919,017.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
480,031,861.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,448,139.48 |
| Total Current Assets |
900,150,173.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
145,707,459.76 |
| Investment Properties |
-- |
| Fixed Assetes |
945,784,048.55 |
| Under-construction Projects |
17,835,833.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
77,105,052.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
31,899,816.14 |
| Deferred Income Tax Assets |
280,293.03 |
| Other Non-Current Assets |
33,680,000.00 |
| Sub-Total of Non-Current Assets |
1,255,993,207.93 |
| Total Assets |
2,156,143,381.31 |
| Short-Term Loans |
720,020,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
178,109,669.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,167,433.63 |
| Taxes Payable |
16,626,413.04 |
| Interest Payable |
-- |
| Dividend Payable |
2,401,874.90 |
| Other payables |
681,684,774.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
972,738.47 |
| Other Current Liabilities |
11,733,110.73 |
| Sub-Total of Current Liabilities |
1,706,661,451.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,430,008.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
25,408,834.26 |
| Total Liabilities |
1,732,070,285.44 |
| Paid-In Capital(Or Share Stock) |
2,032,000,000.00 |
| Capital Surplus |
3,076,692,850.39 |
| Surplus Reserve |
172,703,990.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,819,331,115.90 |
| Minority Stockholder's Interest |
417,247.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
423,655,848.66 |
| Owner's Equity（Stockholder's Equity） |
424,073,095.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,156,143,381.31 |
